Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IBUPROFEN Cause Coronary artery disease? 181 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Coronary artery disease have been filed in association with IBUPROFEN (equate ibuprofen). This represents 0.2% of all adverse event reports for IBUPROFEN.

181
Reports of Coronary artery disease with IBUPROFEN
0.2%
of all IBUPROFEN reports
11
Deaths
49
Hospitalizations

How Dangerous Is Coronary artery disease From IBUPROFEN?

Of the 181 reports, 11 (6.1%) resulted in death, 49 (27.1%) required hospitalization, and 4 (2.2%) were considered life-threatening.

Is Coronary artery disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IBUPROFEN. However, 181 reports have been filed with the FAERS database.

What Other Side Effects Does IBUPROFEN Cause?

Drug ineffective (9,352) Drug hypersensitivity (5,269) Nausea (4,129) Vomiting (4,116) Acute kidney injury (3,639) Product use in unapproved indication (3,596) Toxicity to various agents (3,584) Off label use (3,556) Intentional overdose (3,185) Headache (3,010)

What Other Drugs Cause Coronary artery disease?

ROSIGLITAZONE (4,982) ASPIRIN (807) METFORMIN\ROSIGLITAZONE (738) AVANDIA (667) ROSUVASTATIN (508) TESTOSTERONE (453) PANTOPRAZOLE (422) CLOPIDOGREL BISULFATE (402) ALBUTEROL (391) ADALIMUMAB (353)

Which IBUPROFEN Alternatives Have Lower Coronary artery disease Risk?

IBUPROFEN vs IBUPROFEN LYSINE IBUPROFEN vs IBUPROFEN UNKNOWN PRODUCT IBUPROFEN vs IBUPROFEN\IBUPROFEN IBUPROFEN vs IBUPROFEN\PHENYLEPHRINE IBUPROFEN vs IBUPROFEN\PSEUDOEPHEDRINE

Related Pages

IBUPROFEN Full Profile All Coronary artery disease Reports All Drugs Causing Coronary artery disease IBUPROFEN Demographics